India’s pharmaceutical sector needs a stronger shift towards non-animal testing methods for drug development. The Hindu says organoids, organ-on-chip systems, advanced computation, and artificial intelligence can improve prediction of human outcomes, reduce development time, and support safer decision-making in drug discovery.
The Hindu highlights organoids, organ-on-chip systems, advanced computation, and artificial intelligence as the main tools in the next phase of research. These methods are grouped under new approach methodologies (NAMs).
Related current affairs
- E. Explained: Cigenting bacterium, what challenges remain in an anti-cancer pathway
- Non-animal testing is key to next phase of pharma growth
- Message from H? and others: Known science on the hormone with broader, and less substant? (headline unclear)
- Jitin Prasada holds bilateral meetings in Morocco on trade, investment and digital transformation
- What changes when AI moves from reading viral genomes to designing them?
- Google’s AI advantage faces its biggest test yet